InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP Life Sciences Forum 2019

September 18, Convene 810 Seventh Ave, New York


Register here

Registration is now open - confirm your place online

Free registration for in-house IP/patent counsel, general counsel and heads of legal 
Law firms, IP service providers and consultancies save $300 before August 2

Managing IP is excited to announce the return of the fourth annual MIP Life Sciences Forum 2019 taking place at the Convene 810 Seventh Ave, New York  on  September 18 .This one day forum will address the latest decisions and tumultuous changes affecting the life sciences industry today.

While AbbVie Inc. and Boehringer Ingelheim GmbH may have settled their biosimilar dispute in relation to Humira, the FDA's recent approval of Samsung Bioepis's biosimilar was at the same time followed by the almost immediate launch of litigation by Amgen in response

These two cases represent how difficult and complex the curent landscape for patent prosecution and litigation is right now in the biosimilars markets and beyond. While the threats are huge, the opportunities have never been greater for those get their patent prosecution, protection, litigation, and commercialization strategies right.

By attending, you will be able to benchmark your practices against those of your peers, and understand what you need to do to take advantage of the considerable opportunities available, while at the same time protecting your patents and minimising your risk.

Download brochure

Benefits of attending

  • Take a closer look at biologics and expansion in the biosimilars arena
  • Hear comprehensive coverage of the latest decisions and developments in the Supreme Court, PTAB and the Federal Circuit
  • Assess the Canadian patent landscape
  • Pinpoint the hot issues in international litigation; and
  • Seek to understand what makes a successful partnership and commercial strategy currently

Who will you meet?

  • IP in-house counsel
  • Patent counsel
  • Heads of IP
  • Directors of IP
  • Judges
  • Private practice lawyers

Kevin Pragas
+44 207 779 8938

Raf O'Reilly

Melanie Petch
+44 207 779 8836


More from the Managing IP blog

null null null



July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable

Most read articles